Sign up to Seedtable
Get unlimited access to our database of 17,248 companies. Cancel anytime.
Full database access with no contact information. New companies added weekly.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
Full database access with verified contact info. New companies added weekly.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
All of Pro, plus we'll exclude your top three competitors as new Intel customers.
- Access 17k companies (and growing) with unlimited exports
- Filter by geography, business model, industry, money raised and more
- Score to find fast-growing companies
- Likely to Outsource tag to understand if a company is looking for your services
- Verified email addresses so you can contact people directly
- Personalized 1:1 onboarding by a cold email expert
Free plan includes the ability to browse the database and a list of the top 10 companies of the week, every Tuesday in your email. You need to upgrade if you want to see more than 10 companies, sort, filter or export data.
world-class organizations
69 Deep Tech Startups in UK to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Ethereum-based token streaming platform. |
$5M · Seed | Circle Ventures, Multicoin Capital, Safe | 11 to 50 | Fintech, Deep Tech | B2B, SaaS | London, UK | •••••••••••@superfluid.finance | |
Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits. |
$28M · Series B | Future Planet Capital | 11 to 50 | Agritech, Biotech, Deep Tech, Manufacturing | B2B | London, UK | •••••••••••@tropicbioscience.com | |
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. |
$25M | Kindred Capital, Atomico | 51 to 100 | Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@labgeni.us | |
Immuno-oncology company treats cancer with antibodies. |
$2M · Series A | AlbionVC, Epidarex Capital, Novartis Venture Fund | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics | B2B | London, UK | •••••••••••@epsilogen.com | |
OS for electricity grids. |
$10M · Series B | Clean Growth Fund, Future Energy Ventures | 11 to 50 | Climate Tech & Green Tech, Deep Tech, Energy & Nuclear | B2B, Marketplace | London, UK | •••••••••••@piclo.energy | |
Silicon-oxide based RRAM technologies. |
$8M · Series A | Octopus Ventures | 1 to 10 | Deep Tech, Semiconductor | London, UK | •••••••••••@intrinsicsemi.com | ||
Flexciton is the intelligent advantage platform for streamlined chipmaking |
$3M · Seed | BACKED VC, Entrepreneur First, Join Capital | 11 to 50 | AI, Deep Tech, Machine Learning, Manufacturing, Semiconductor | B2B | London, UK | •••••••••••@flexciton.com | |
SLAMcore provides location, mapping and perception software for robots and other autonomous machines to become spatially intelligent |
$5M | Octopus Ventures, MMC Ventures, Amadeus Capital | 11 to 50 | AI, AR / VR, Deep Tech, Drones, Data and Analytics, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@slamcore.com | |
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors. |
$6M · Seed | Sofinnova Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@myricxpharma.com | |
Generative engineering platform for physical products. |
$4M · Pre Seed | EQT Ventures, Join Capital | 11 to 50 | Deep Tech, Manufacturing | B2B, SaaS | London, UK | •••••••••••@generative.vision | |
Humanising Autonomy is building the global standard for human machine interactions. |
$5M · Seed | Anthemis | 11 to 50 | AI, Deep Tech, Proptech & Real Estate, Machine Learning, Music and Audio, Data and Analytics, Mobility & Transportation | B2B | London, UK | •••••••••••@humanisingautonomy.com | |
Karakuri is revolutionising Quick Service (QSR) and Fast Casual restaurants with intelligent, robotic kitchen automation. |
$8M · Seed | Hoxton Ventures, Firstminute Capital | 11 to 50 | Foodtech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@karakuri.com | |
BotsAndUs captures real-time insights of warehouse operations using fully autonomous robots and Artificial Intelligence. |
$6M | Kindred Capital, Lakestar, Capnamic Ventures | 11 to 50 | AI, Deep Tech, Data and Analytics, Robotics, Manufacturing, Ecommerce | B2C, SaaS | London, UK | •••••••••••@botsandus.com | |
3D human lung model developer. |
$2M · Seed | Pioneer Group, Mercia Asset Management, Midlands Engine Investment Fund | 11 to 50 | Biotech, Deep Tech | London, UK | •••••••••••@immuone.com | ||
Protein discovery research and manufacturing. |
$19M · Series A | SYSTEMIQ | 11 to 50 | Biotech, Deep Tech | London, UK | •••••••••••@basecamp-research.com | ||
Intelligent test automation. |
$6M · Series A | YFM Equity Partners | 11 to 50 | Deep Tech | London, UK | •••••••••••@automatepro.com | ||
7bridges is an AI-powered optimization engine for businesses to scale and automate logistics and supply chains. |
$3M · Seed | Local Globe, Crane Venture Partners, Eight Roads Ventures | 11 to 50 | AI, Deep Tech, Data and Analytics | B2B, SaaS | London, UK | •••••••••••@the7bridges.com | |
Perfect Ward is the health and quality inspection solution. |
$5M · Series A | octopus investments | 11 to 50 | Health Tech, Deep Tech, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@perfectward.com | |
Decentralised trading platform. |
$2M · Pre Seed | Speedinvest, Keyrock, Daedalus Angel Syndicate | 11 to 50 | Deep Tech, Investing | B2B, SaaS | London, UK | •••••••••••@rho.trading | |
Software for autonomous vehicles. |
$140M · Series C | Kiko Ventures, Business Growth Fund | 251 to 500 | AI, Deep Tech, Machine Learning, Music and Audio, Mobility & Transportation | B2B, SaaS | Oxford, UK | •••••••••••@oxbotica.ai | |
Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. |
$66M | Cambridge Innovation Capital, Seventure Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@microbiotica.com | |
Transforming mental healthcare by unlocking the power of clinical data |
$52M · Series B | Molten Ventures | 101 to 250 | Health Tech, Deep Tech | B2B, B2C | Cambridge, UK | •••••••••••@iesogroup.com | |
ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers. |
$75M · Series B | Axon Ventures, Oxford Science Enterprises | 51 to 100 | Health Tech, Biotech, Deep Tech, Robotics, Manufacturing, Developer Tools | B2B | Oxford, UK | •••••••••••@oni.bio | |
MiroBio is Harnessing the natural control mechanisms of the immune system. |
$97M · Series B | Medicxi, Oxford Science Enterprises | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | Oxford, UK | •••••••••••@mirobio.com | |
Lab-quality diagnostics for anyone, anywhere, at any time. |
$85M | Oxford Science Enterprises | 51 to 100 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Oxford, UK | •••••••••••@oslerdiagnostics.com | |
Brytlyt is a young and dynamic company with a clear mission – to empower organisations through transformational data analytics. |
$4M | AlbionVC, Finch Capital, Amadeus Capital | 11 to 50 | Hardware, Deep Tech, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@brytlyt.com | |
Large language model (LLM) data insights platform. |
$1M · Pre Seed | 500 Emerging Europe, Episode 1 | 1 to 10 | Deep Tech | B2B, SaaS | London, UK | •••••••••••@getsentify.ai | |
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers. |
N/A | Forbion Capital Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@pheontx.com | |
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies. |
$10M · Series A | Astellas Venture Management, Ahren Innovation Capital, Parkwalk Advisors | 101 to 250 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@mogrify.co.uk | |
Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis. |
$42M · Series B | Future Planet Capital, Amadeus Capital, Verve Ventures | 11 to 50 | Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@nuclera.com | |
Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell. |
$41M · Series A | Metaplanet Holdings, BlueYard Capital | 101 to 250 | Health Tech, Biotech, Deep Tech, Business Intelligence | B2B | Cambridge, UK | •••••••••••@bit.bio | |
Puraffinity develops precision materials to target chemicals, with an initial focus on PFAS in water |
$3M · Seed | Kindred Capital, Verve Ventures | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing | B2B | London, UK | •••••••••••@puraffinity.com | |
Foodsteps is a london-based startup that has developed a platform to help the food sector reduce its carbon footprint. |
$4M | Octopus Ventures, Ascension Ventures, Metaplanet Holdings | 11 to 50 | Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@foodsteps.earth | |
Synthace is a Life Sciences R&D cloud platform that enables experiments to be automated, with the resultant data seamlessly integrated. |
N/A | Sofinnova Partners | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Internet of Things | B2B, SaaS | London, UK | •••••••••••@synthace.com | |
Synthetic data cloud platform. |
$290k · Pre Seed | Edge VC, High-Tech Gründerfonds, Cogito Capital Partners | 11 to 50 | Deep Tech, Data and Analytics | B2B, SaaS | London, UK | •••••••••••@skyengine.ai | |
Ordinals infrastructure paltform for developers. |
$1M · Seed | Kestrel 0x1, Lightning Ventures, Bitcoin Frontier Fund | 1 to 10 | Crypto & web3, Deep Tech | B2B | London, UK | •••••••••••@ordinalsbot.com | |
Arrival is a developer and manufacturer of zero-emission, public transportation vehicles. |
$111M · Series A | 1001 to 5000 | Climate Tech & Green Tech, Hardware, Deep Tech, Music and Audio, Mobility & Transportation, Manufacturing, Electric Vehicles | B2B | London, UK | •••••••••••@arrival.com | ||
Blockchain infrastructure and tooling platform. |
$2M · Seed | Klaytn, NexusOne, Gate.io | 11 to 50 | Crypto & web3, Deep Tech | B2B, SaaS | London, UK | •••••••••••@kanalabs.io | |
Supplant is a biotechnology platform that makes sugar substitutes. |
$24M | Khosla Ventures, Felicis Ventures, Y Combinator | 11 to 50 | Health Tech, Foodtech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@supplant.com | |
Metrion Biosciences is a Contract Research Organization. |
$4M · Series A | Gresham House Ventures, NPIF Maven Equity Finance | 11 to 50 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@metrionbiosciences.com | ||
Cancer diagnostics. |
$16M · Series A | Business Growth Fund | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cyted.ai | ||
Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology. |
$11M · Seed | GV, Forbion Capital Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Cambridge, UK | •••••••••••@mestagtx.com | |
Immunotherapy for bladder cancer. |
$30M · Series B | 11 to 50 | Health Tech, Biotech, Deep Tech | London, UK | •••••••••••@prokarium.com | |||
One lab management platform that brings people, equipment and data together - no matter where they are. |
$1M | Forward Partners | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B, SaaS | London, UK | •••••••••••@clustermarket.com | |
Exogene is a biotechnology company accelerating target & TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening. |
$104k · Pre Seed | Atomico, Entrepreneur First | 1 to 10 | Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics | B2B | London, UK | •••••••••••@exogene.co.uk | |
Neurofenix is aiming to make rehabilitation more autonomous, enjoyable and accessible to stroke victims. |
N/A | AlbionVC, InHealth Ventures | 1 to 10 | Health Tech, Hardware, Deep Tech, Music and Audio, Mobility & Transportation, Manufacturing, Service Industry | B2B | London, UK | •••••••••••@neurofenix.com | |
MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms. |
$29M | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Genetics | B2B | London, UK | •••••••••••@minatx.com | ||
Mindstep towards better better brain health. |
$450k · Pre Seed | Octopus Ventures, Calm/Storm Ventures | 11 to 50 | Health Tech, Hardware, Deep Tech, Mobile, Business Intelligence | B2B, B2C | London, UK | •••••••••••@letsmindstep.com | |
PetMedix is a pet therapeutics startup. |
$13M · Series A | Cambridge Innovation Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@petmedix.co.uk | |
Biofidelity developed a revolutionary molecular diagnostics. |
$12M · Series A | Octopus Ventures, BlueYard Capital | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Cambridge, UK | •••••••••••@biofidelity.com | |
Supplier of configurable process node agnostic analog IP building blocks. |
$5M · Seed | Omers Ventures, Firstminute Capital, MMC Ventures | 11 to 50 | Deep Tech, Manufacturing, Semiconductor | B2B | Cambridge, UK | •••••••••••@agileanalog.com | |
Keelvar offers advanced sourcing optimization and intelligent sourcing automation software. |
$18M · Series A | 83North, Mosaic Ventures, Paua Ventures | 101 to 250 | Deep Tech, Robotics, Manufacturing, Supply Chain & Logistics, IT Management | B2B, SaaS | Cork, UK | •••••••••••@keelvar.com | |
Manufacturer of deployable antennas for spacecraft. |
$3M · Seed | UK Innovation & Science Seed Fund | 11 to 50 | Deep Tech, Space Tech | Oxford, UK | •••••••••••@oxford.space | ||
SenSat simulates reality in real time, which helps computers solve real world problems. |
$10M | 51 to 100 | Deep Tech, Data and Analytics, Privacy and Security, Manufacturing | B2B, SaaS | London, UK | •••••••••••@sensat.co.uk | ||
Nuntius Therapeutics is pioneering a new class of targeted RNA, DNA and CRISPR therapies. |
$125k · Pre Seed | Y Combinator | 1 to 10 | Health Tech, Biotech, Deep Tech | B2B | London, UK | •••••••••••@nuntiustx.com | |
Syrona Health is a personalised digital health platform for Chronic Gynaecological/Uterine Conditions like Endometriosis, PCOS etc. |
$253k · Seed | Y Combinator, Katapult Accelerator | 1 to 10 | Health Tech, Biotech, Deep Tech, Femtech, Ecommerce, ElderTech, Fertility | B2B | London, UK | •••••••••••@syronahealth.com | |
Bluezone Insurance offers personalized, same-day life cover for people with chronic conditions, like type 2 diabetes and heart diseases. |
$1M · Seed | Insurtech Gateway, Portfolio Ventures | 1 to 10 | Health Tech, Fintech, Biotech, Deep Tech, Insuretech | B2C | London, UK | •••••••••••@bluezoneinsurance.co.uk | |
Biorelate provides biomedical research services. |
$7M | Triple Point Ventures | 11 to 50 | Health Tech, Biotech, Deep Tech, Data and Analytics | Manchester, UK | •••••••••••@biorelate.com | ||
Manufacturer of growth factor proteins for stem cell, organoid and cellular agriculture applications. |
$5M · Series B | Parkwalk Advisors, Downing Ventures | 11 to 50 | Biotech, Deep Tech | Cambridge, UK | •••••••••••@qkine.com | ||
Polymateria is a London-based startup advancing science to help nature deal with plastic pollution. |
$18M | 11 to 50 | Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing | B2B | London, UK | •••••••••••@polymateria.com | ||
Epitopea is a transatlantic cancer immunotherapeutics company. |
$13M · Seed | Cambridge Innovation Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | Cambridge, UK | •••••••••••@epitopea.com | |
A synthetic antibody company based in East Midlands, UK. |
$6M | Calculus Capital, Business Growth Fund | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B, B2C, SaaS | Leicester, UK | •••••••••••@mip-dx.com | |
Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology |
$6M · Series A | IQ Capital Partners, Techstart Ventures | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Manufacturing, Wearables | B2B | Belfast, UK | •••••••••••@neurovalens.com | |
Sphere Fluidics develops products for use in single cell analysis and characterization, and provides associated collaborative R&D services. |
$4M | Sofinnova Partners | 11 to 50 | Health Tech, Deep Tech | B2B | Cambridge, UK | •••••••••••@spherefluidics.com | |
Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw. |
$88M · Series D | 51 to 100 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@cambridge-epigenetix.com | |||
Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies. |
$152M · Series C | 101 to 250 | Health Tech, Deep Tech | Cambridge, UK | •••••••••••@artiospharma.com | |||
Seyo is the trading name of Seyo Limited a company registered (Company Number: 11701852) in England and Wales. |
N/A | Entrepreneur First, 7percent Ventures, Ascension Ventures | 1 to 10 | Deep Tech, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@seyo.io | |
CoMind is a noninvasive neural technology company building next-generation neural interfaces. |
N/A | Entrepreneur First | 1 to 10 | Health Tech, Hardware, AI, Deep Tech, Machine Learning, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@comind.io | |
Opteran operates as a natural intelligence company. |
$2M | Episode 1, IQ Capital Partners, Join Capital | 1 to 10 | AI, Deep Tech, Robotics, Manufacturing | B2B | Sheffield, UK | •••••••••••@opteran.com |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.